CD22 and myeloid sarcoma: Through the analysis of the PPI network, we identified several hub genes potentially involved in the pathogenesis of MS, including PTPRC, CD19, CXCL8, CD79A, IL7, CR2, CD22, BLNK, LCN2, and LTF.